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Abstract
Background: Most human genes produce several transcripts with different exon contents by
using alternative promoters, alternative polyadenylation sites and alternative splice sites. Much
effort has been devoted to describing known gene transcripts through the development of
numerous databases. Nevertheless, owing to the diversity of the transcriptome, there is a need for
interactive databases that provide information about the potential function of each splicing variant,
as well as its expression pattern.
Description: After setting up a database in which human and mouse splicing variants were
compiled, we developed tools (1) to predict the production of protein isoforms from these
transcripts, taking account of the presence of open reading frames and mechanisms that could
potentially eliminate transcripts and/or inhibit their translation, i.e. nonsense-mediated mRNA
decay and microRNAs; (2) to support studies of the regulation of transcript expression at multiple
levels, including transcription and splicing, particularly in terms of tissue specificity; and (3) to assist
in experimental analysis of the expression of splicing variants. Importantly, analyses of all features
from transcript metabolism to functional protein domains were integrated in a highly interactive,
user-friendly web interface that allows the functional and regulatory features of gene transcripts to
be assessed rapidly and accurately.
Conclusion: In addition to identifying the transcripts produced by human and mouse genes, fast
DB http://www.fast-db.com provides tools for analyzing the putative functions of these transcripts
and the regulation of their expression. Therefore, fast DB has achieved an advance in alternative
splicing databases by providing resources for the functional interpretation of splicing variants for
the human and mouse genomes. Because gene expression studies are increasingly employed in
clinical analyses, our web interface has been designed to be as user-friendly as possible and to be
readily searchable and intelligible at a glance by the whole biomedical community.
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Background
Human genes are transcribed as messenger RNA precursor
molecules (pre-mRNAs), which are composed of short
exons separated by much longer introns. The introns are
removed during the splicing process, which gives rise to
mature mRNAs containing only exons. Genome-wide
analyses indicates that most (up to 70%) human genes
generate different transcripts with different exon contents
by using alternative promoters, alternative polyadenyla-
tion sites and alternative splice sites [1-3]. About 40% of
human genes produce at least five different splicing vari-
ants (SVs) and up to 10% of them produce more than 10
alternate transcripts each [4,5]. With such diversity and
complexity, it becomes difficult to apprehend the role and
impact of the transcriptome in terms of cellular function.
A first step was attained by several large-scale studies
showing that 75% of alternative splicing (AS) events occur
in translated regions of mRNAs and have consequences at
the protein level. The resulting changes in amino acid
sequence can alter the binding properties of proteins,
influence their intracellular location, and modify their
enzymatic activity and/or stability [2]. This leads to a gain,
an alteration, or even a complete loss of function. Impor-
tantly, although a given transcript can be predicted to pro-
duce a particular protein isoform, its translation can be
inhibited by several mechanisms or it can be degraded.
These mechanisms include nonsense-mediated mRNA
decay (NMD) [6-8] and targeting of microRNAs (miRNA)
[9-11]. The NMD pathway leads to the degradation of
mRNAs that contain a premature stop codon, i.e. a stop
codon more than 50 nucleotides upstream of any exon/
exon junction [6,7]. MiRNAs are 21- to 25-nucleotide-
long RNAs that can either induce the degradation or sup-
press the translation of mRNAs, depending on whether
they match their targets perfectly or approximately [9].
Several databases based on different algorithms able to
predict miRNA targets have been constructed [12-14]. In
addition to considering the production of protein iso-
forms from SVs, biologists are interested in their expres-
sion patterns. Global gene expression, promoter use and
SV expression can be specific to a tissue or a group of tis-
sues [15,16]. Therefore, to apprehend transcriptome
diversity and complexity, it is now necessary to develop
interactive databases that provide tools for predicting the
functions of SVs as well as their tissue expression patterns.
Having compiled human and mouse splicing variants in a
database named fast DB [4], we now provide resources for
functional interpretation of SVs. Indeed, this new release
of fast DB provides a predicted open reading frame (ORF)
for each known transcript, and helps predict the func-
tional consequences of AS events by an analysis of protein
domains encoded by alternative exons. Moreover, fast DB
now predicts whether transcripts are potential targets for
an NMD pathway and/or miRNA. Finally, this new ver-
sion of fast DB provides tools for studying the expression
and regulation of SVs. In particular, fast DB now provides
tissue distribution charts of each gene and AS event to
help study the tissue specificity of AS events.
Construction and content
Definition of exons and AS events
Genomic sequence and orthologous relationships
We recovered human genomic sequences of the 22,218
"protein coding" genes from the
homo_sapiens_core_31_35d EnsEMBL database [17].
Mouse genomic sequences came from the
mus_musculus_core_35_34d EnsEMBL database. We
used the ensemble_compara_36 database to associate
each human gene with its orthologous mouse gene.
Transcript selection
To define exon/intron structures and alternative splicing
events, we aligned transcript sequences against genomic
sequence using sim4 [18]. "Full length" mRNAs and
expressed sequence tags (ESTs) came from the UCSC web-
site as available in January 2006 [19] and "partial"
mRNAs were downloaded from the NCBI website [20].
Transcripts were selected using very stringent criteria (see
the fast DB documentation).
Definition of "genomic exons" and AS events
We defined a "genomic exon" as the most frequently-
occurring transcript exon at a given genomic position.
Alternative events were defined by comparing transcript
exons with the corresponding genomic exons (see the fast
DB documentation). Statistics of AS events in fast DB are
available on the fast DB website.
Known coding sequences
To display information about known translation prod-
uct(s), fast DB shows the known coding sequence(s)
(CDS) for most human genes. We downloaded data from
the Consensus CDS database (CCDS) as available on
March 2, 2005 [21]. Using EnsEMBL transcript accession
(e.g. ENST00000343008), we associated 12,201 fast DB
human genes with at least one CDS from the CCDS data-
base, which contains CDS from 13,142 human genes. On
average, each fast DB human gene was associated with 1.1
CDS from the CCDS database.
Prediction of open reading frames
To help predict the impact of AS on protein function, fast
DB presents interactive graphical representations of ORFs
for most human and mouse cDNAs. In some cases, two
ORFs are predicted for the same SV (Figure 2, items 5 of
[GenBank:BC063849]). We used the "getorf" program
from the EMBOSS package [22] to find all ORFs of at least
120 nucleotides ("getorf -minsize 120 -reverse No file_in
file_out"). We then selected the two longest ORFs. TheBMC Bioinformatics 2007, 8:180 http://www.biomedcentral.com/1471-2105/8/180
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first of these (blue ORFs in Figure 2, items 5) corresponds
to the ORF covering the greatest number of transcript
exons. If there are AS events before or within the first exon
covered by the first selected ORF, fast DB displays the sec-
ond (red ORF of the [GenBank:BC063849] transcript in
Figure 2, item 5). Using this algorithm, fast DB provides
ORF predictions for 111,893 human cDNAs (99.4% of
the 112,609 human cDNAs) and 76,391 mouse cDNAs
(97.7% of the 78,170 mouse cDNAs). Two predicted
ORFs are displayed for 8,450 (7.5%) human cDNAs and
for 4,780 (6.1%) mouse cDNAs.
Prediction of nonsense-mediated mRNA decay
To predict whether a given transcript is a target for the
NMD pathway, we calculated nucleotide length between
the stop position (on the transcript sequence) and the
position of the last exon-exon junction. If this length is
greater than 50, the corresponding SV is predicted to be
targeted by NMD. Fast DB labels each predicted ORF with
an "ORF" flag, or with an "NMD" flag if NMD targeting is
predicted. Among all human cDNAs, 13% (14,667 of
112,609) have at least one transcript labeled "NMD"
[14,667 (31%) of 47,923 of alternate human cDNAs].
Prediction of microRNA/transcript interaction sites
To predict whether a given exon is a potential target for a
miRNA, we downloaded a file with all predicted miRNA/
transcript interaction sites from the miRBase Targets data-
base version 2.0 [13]. This file contains miRNA names,
chromosome names and chromosomal positions. From
these positions, we realigned the miRNA sequences with
corresponding genomic sequences using the miRanda
program [23]. Interaction sites with a maximum energy of
-19 were stored in the fast DB MySQL database [24]. Each
transcript sequence within the alignment region was
aligned with the genomic sequence using Clustalw [25],
and differences between genomic and transcript
sequences were highlighted in red in order to predict
whether they potentially affect miRNA/transcript interac-
tion. A total of 78,903 miRNA/transcript interaction sites
were predicted between 11,301 human genes (63% of the
18,008 human genes) and 413 microRNAs.
Association of transcript with tissue
To provide a tissue-specificity analysis of each AS event,
we associated each human transcript (cDNAs and ESTs)
with the tissue from which it had been cloned. Where
information was available, we recovered the name of the
transcript library from CGAP [26], and where the library
was associated with a tissue, we associated tissue with
transcript using a keyword search system written in Perl
[27] among a collection of 36 tissues and groups of tissues
(see the fast DB documentation). If a transcript was not
associated with a library, or if its library was not associated
with a tissue, we used our keyword search system on the
"tissue_type" field of the transcript GenBank file (where
this field was available). Using this algorithm, 87% of fast
DB transcripts were associated with one of the 36 tissues.
Among the 1,154,554 transcripts stored in the fast DB
database, 875,479 (76%) were associated with a tissue
using the library information and 132,740 (11%) were
associated with a tissue using their "tissue_type" informa-
tion. A histogram of tissue distribution of all the fast DB
cDNAs and ESTs is available in the fast DB documentation
and on the fast DB website (Figure 5A, item 1).
Tissue distribution histogram of all gene transcripts
To enable the expression pattern of a given gene to be vis-
ualized clearly, fast DB displays a histogram of the tissue
distribution of all its transcripts. Once the transcripts had
been associated with the tissue from which they were
cloned, we used the Perl module GD::Graph to draw this
histogram. Transcripts not associated with a tissue were
placed in the "n/a" group. Only tissues in which tran-
scripts are expressed were represented on the chart.
Tissue distribution histogram of gene transcripts for a 
specific event
To go further, fast DB provides a histogram of the tissue
distribution of transcripts for each transcriptional and
splicing event.
Analysis of alternative first exons
All the different alternative first exons were represented on
the same chart. For each alternative first exon, we identi-
fied the transcripts for which this event was defined. All 5'-
partial transcripts were excluded from this study, i.e. tran-
scripts for which no alternative first exon was defined (see
the fast DB documentation).
Analysis of alternative terminal exons
As for the alternative first exons, all the different alterna-
tive terminal exons were represented on the same chart.
For each alternative terminal exon, we identified the tran-
scripts for which this event was defined. All 3'-partial tran-
scripts were excluded from this study, i.e. transcripts for
which no alternative terminal exon was defined (see the
fast DB documentation).
Exon skipping
Several groups of transcripts were represented on the
chart. The first group comprises transcripts for which exon
skipping is defined (see the fast DB documentation). The
next group comprises transcripts that include the corre-
sponding exon(s). The last group can be divided into sub-
groups according to splicing events defined as adjacent to
the event studied. For this purpose, we defined a pair of
values corresponding to the positions of splice sites flank-
ing the skipped exon(s) (Figure 5B, items 2). For each pair
of values, a group was represented on the chart, in addi-BMC Bioinformatics 2007, 8:180 http://www.biomedcentral.com/1471-2105/8/180
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tion to the group of transcripts for which exon skipping
was defined.
Intron retention
As for exon skipping, several groups of transcripts were
represented on the chart. The first group consists of tran-
scripts for which intron retention is defined (see the fast
DB documentation). The other consists of transcripts that
splice introns (genomic or nongenomic introns), which
are included in transcripts defining the alternative event.
For a single chosen intron, four values were defined (cor-
responding to the splice sites of the exons flanking the
chosen intron). For each group of values, a transcript
group was represented on the chart, in addition to the
group of transcripts for which intron retention was
defined.
Alternative 3'and 5' splice sites
Several distinct groups of transcripts were represented on
the chart. Each group corresponds to a different pair of
acceptor/donor splice sites (see the fast DB documenta-
tion).
Utility
Fast DB can be searched using various criteria such as
gene, transcript or protein IDs, keywords, and chromo-
somal location (Figure 1A, item 1). A blast search is avail-
able (Figure 1A, item 2), and a list of genes can also be
retrieved by uploading a file gathering the stable EnsEMBL
ID of these genes (Figure 1A, item 4 and see the fast DB
documentation). A list of genes with similar characteris-
tics can also be retrieved using the fast DB advanced
search page (Figure 1B). The criteria available for gene
selection include gene length (Figure 1B, item 1), number
of exons (Figure 1B, item 2), number of transcripts (Figure
1B, item 3), chromosomal location (Figure 1B, items 4
and 5), type of AS event (Figure 1B, item 6), and NMD-tar-
geted transcript prediction (Figure 1B, item 7). After a spe-
cific gene is selected, its main page presents its exon/
intron structure and general information regarding splic-
ing of its transcripts [4]. From there, three kinds of analy-
ses are available, based on human mRNAs, human
mRNAs and ESTs, and mouse mRNAs. After choosing one
option, the user can click on the "transcripts view" button.
The "transcripts view" page (Figure 2) provides a diagram
of the exon/intron structure of the gene (Figure 2, item 1)
and the exon content of its transcripts (Figure 2, items 2),
with AS events in red (Figure 2, items 3).
Of the 18,008 human genes present in our database,
11,071 (61%) were estimated to undergo AS. This result is
consistent with other studies, which estimate that 40–
75% of human genes are alternatively spliced [1-3,28,29].
Using 112,609 cDNAs mapped to the human genome, we
defined 5,663 cassette exons, 3,940 intron retentions,
6,483 alternative acceptor sites and 5,551 alternative
donor sites. Finally, 26% and 22% of the fast DB genes
present alternative first and alternative terminal exons,
respectively. These results are highly consistent with those
of other databases [5,30-35]. More detailed statistics can
be found on the fast DB website.
The fast DB search pages Figure 1
The fast DB search pages. (A) The fast DB basic search 
page. (1) Keyword search; (2) Blast search; (3) checkbox to 
align an input sequence with a graphical representation of the 
exon/intron gene structure; (4) multiple-queries search: the 
user can upload a file with a stable gene EnsEMBL ID at each 
line. (B) The fast DB advanced search page. (1) Minimal and 
maximal length selection in base pairs; (2) selection of mini-
mal and maximal number of exons; (3) selection of minimal 
and maximal number of cDNAs; (4) chromosome selection; 
(5) chromosome strand selection; (6) alternative transcrip-
tional and splicing event selection; (7) NMD pathway target-
ing prediction selection.
1
2
3
4
1
2
3
6
4
5
6
6
6
6
6
6
7
A
BBMC Bioinformatics 2007, 8:180 http://www.biomedcentral.com/1471-2105/8/180
Page 5 of 14
(page number not for citation purposes)
Prediction of protein isoform production from gene 
transcripts in fast DB
Prediction of alternative coding sequence functions
Fast DB integrates information and tools for predicting
the functional consequences of AS. To do that, fast DB first
displays the known CDS(s) under the gene representation
(Figure 2, item 4) and provides a predicted ORF for most
transcripts (Figure 2, items 5). The known CDS(s) can be
clicked on to open the corresponding CCDS page on the
NCBI website. In order to compare transcript ORF frames
with each other and/or the frame of known CDS(s),
methionine positions are indicated on the ORF charts
(Figure 2, items 6). Methionines also indicate potential
translation initiation sites, as translation can be initiated
from downstream in-frame AUG codons [36]. AS modi-
fies the amino acid composition and therefore changes
functional and/or structural protein domains by inserting,
altering or completely deleting a domain. To help the user
predict the effect of AS on protein function, each exon,
particularly alternatively spliced exons, can be submitted
directly to external functional protein domain prediction
tools. The user just clicks on the transcript ORF of interest
to open the corresponding analysis page (Figure 3A). This
page shows a diagram representing the selected ORF,
graphically aligned under the corresponding transcript
and gene locus (Figure 3A, item 1). As the graphical repre-
sentation of the gene shows AS events in red, the user can
easily select alternative exons to analyze (Figure 3A, item
2). Once the choice of exon is validated, the correspond-
ing amino acid sequence is displayed (Figure 3A, item 3),
and the user can select an external website to predict the
functional domain encoded within the selected exon [37-
42] (Figure 3A, item 4). In addition to AS, short variations
in nucleotide sequence due to polymorphisms or muta-
tions can lead to a frameshift or to a single amino acid
deletion, insertion or substitution. In order to visualize
these potential amino acid polymorphisms, fast DB pro-
vides a multi-alignment of all translated sequences of pre-
dicted ORFs and known CDS(s), exon by exon (Figure
3B). Amino acids encoded within an exon/exon junction
The fast DB "transcripts view" page of theRANBP9 human gene Figure 2
The fast DB "transcripts view" page of theRANBP9 human gene. (1) Graphical representation of the exon/intron 
gene structure. (2) Graphical representation of exon content of each transcript aligned with graphical representation of the 
gene. (3) AS events are highlighted in red. (4) Known CDS from the CCDS database. (5) Predicted ORFs. (6) Methionine posi-
tions are represented by a green "M". (7) Link to a multi-alignment of all translated ORF sequences. (8) Predicted NMD. (9) 
Exon with at least one predicted microRNA/transcript interaction site.
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are shown in red (Figure 3B, item 1), methionines in
green (Figure 3B, item 2); stop codons are shown with a
red asterisk (Figure 3B, item 3), amino acid polymor-
phisms are highlighted yellow (data not shown), and
known CDSs are highlighted light green (Figure 3B, item
4).
Prediction of no protein production: NMD pathway and miRNA 
targeting
It is now recognized that many transcripts are not trans-
lated, or are poorly translated, owing to rapid degradation
and/or translational repression through the NMD path-
way and/or miRNA targeting. It is therefore important to
predict whether transcripts are likely to be subject to such
regulations. In addition, to diversify the proteome by
changing the protein domain composition, AS may mod-
ulate gene expression by generating NMD-targeted vari-
ants. Therefore, in fast DB, transcripts that are predicted to
be targeted by NMD (the stop codon is located more than
50 nucleotides upstream of the most downstream exon/
exon junction) are indicated and labeled by an "NMD"
close to their stop codon (Figure 2, items 8).
By analyzing 18,008 genes in fast DB, we found that
14,667 (31%) of 47,923 SVs were potential targets for the
NMD pathway, which is consistent with a previous report
[8]. However, this number is an underestimate because
mRNAs targeted by the NMD pathway are certainly under-
represented in cDNA databanks owing to their low level of
expression and to the high proportion of 3'-partial tran-
scripts potentially targeted by the NMD pathway.
In addition to predicting whether a transcript is targeted
by the NMD pathway, the fast DB "transcripts view" indi-
cates whether a given transcript is potentially targeted by
miRNAs. On the "transcripts view" page, a red arrow is
displayed under a transcript exon in which at least one
miRNA/transcript interaction site is predicted (Figure 2,
items 9). By clicking on this arrow, a predicted miRNA/
transcript interaction site (or a list of sites in some cases)
is provided, with the name of the miRNA (Figure 4, item
1), the genomic position of the corresponding alignment
(Figure 4, item 2), the length of this alignment (Figure 4,
item 3) and the link to its display (Figure 4, item 4).
MiRNA and genomic sequences are aligned with each
other (Figure 4, item 5), and fast DB presents a multi-
alignment of the corresponding transcript sequences (Fig-
ure 4, item 6). Where they occur, differences between
genomic and transcript sequences are highlighted in red
to predict whether they potentially affect miRNA/tran-
script interaction (data not shown). The effect of miRNA
interaction on mRNA metabolism (i.e. degradation or
translation repression) depends on the extent of comple-
mentarity. For more information on a given predicted
miRNA/transcript interaction site, fast DB provides a link
to the corresponding miRBase Targets webpage (Figure 4,
item 7). Bioinformatic prediction of transcripts being tar-
geted by miRNAs should be viewed with caution. First,
miRNA target genes cannot yet be predicted with com-
plete reliability. Second, regulation by miRNAs is strictly
dependent on the expression of such miRNAs in the cell,
which must be tested experimentally.
Advanced analysis of the regulation of transcript 
expression in fast DB
Prediction of tissue distribution and regulatory features
The expression of SVs may depend on cell type, and some
SVs are only present in a specific tissue or group of tissues
[43]. For each human gene, fast DB provides the tissue dis-
tribution of its transcripts (cDNAs and ESTs) (Figure 5A,
item 3). Furthermore, for each alternative promoter, alter-
native polyadenylation site and AS event, fast DB provides
the tissue distribution of the SVs defining the event (Fig-
ure 5B). For example, two distinct exon skipping events
were defined for the human RANBP9 gene: skipping of
exon 5 and skipping of exons 6 to 8. All AS events are
listed on the right side of the "tissue specificity" page (Fig-
ure 5A, item 3). By clicking on a given event (e.g. skipping
of exon 5), fast DB displays the tissue distribution histo-
gram for the SVs that contain or do not contain exon 5 (in
blue and red, respectively). The group of SVs containing
exon 5 is divided into two subgroups according to splicing
events defined adjacently to the studied event; the first
subgroup corresponds to SVs that include exon 5 without
defining other events (light blue), and the second corre-
sponds to SVs that include exon 5 but do not include
exons 6 to 8 (dark blue). These different subgroups of SVs
are schematically represented on the left side of the page
(Figure 5B, item 1). The tissue distribution chart shows
that skipping of RANBP9  exon 5 occurs specifically in
muscular (and possibly nervous) tissue(s) (Figure 5B,
item 3). A table with the number of transcripts defining
the events in the different tissues is presented (Figure 5B,
item 4).
To provide further support for analyses of the regulation
of transcript expression, each transcript exon from the
"transcripts view" page (Figure 2, items 2) can be clicked
on to analyze its sequence directly. This enables either
promoter, transcription factor or splicing factor binding
site to be predicted, or splice sites strengths to be scored,
and for 5' and 3' UTR sequences to be analyzed, since RNA
sequences regulating mRNA metabolism are usually
located in UTRs [44]. After an exon is clicked on, a new
page opens. Figure 6A presents the analysis of the first
exon in the [GenBank:BC063849] transcript of the
human RANBP9 gene. A table shows the sequences and
scores of splice sites corresponding to the selected exon
(Figure 6A, item 2). In this case, since the selected exon is
the first in the transcript, the acceptor site is not defined.BMC Bioinformatics 2007, 8:180 http://www.biomedcentral.com/1471-2105/8/180
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The sequence and length of the exon are also displayed
under this table (Figure 6A, item 3). The user can select
several kinds of analyses to proceed with this exon (Figure
5A, item 4): transcription analyses, UTR analyses or splic-
ing analyses. Once the kind of analysis is selected (5' UTR
analyses in this example), the user must choose an exter-
nal website to perform it (Figure 6A, item 5). All the pos-
sible websites are listed in Figure 6B.
Tools to assist in experimental analysis of SV expression
Fast DB provides several tools to facilitate experimental
studies of transcript expression. The "in silico PCR" tool
(Figure 7A) displays a multi-alignment of all the different
transcripts of a given gene that represents their common
and specific sequences. Therefore, it becomes easy to
design probes for downstream experimental applications,
particularly PCR amplification. Thanks to the fast DB in
silico PCR, the user can in a few minutes design primers for
PCR amplification of all the transcripts as a single PCR
Functional protein domain analysis andmulti-alignment of the translated sequences of predicted ORFs Figure 3
Functional protein domain analysis andmulti-alignment of the translated sequences of predicted ORFs. (A) 
Functional protein domain analysis of the [GenBank:AB055311] transcript. (1) Diagram of the [GenBank:AB055311] ORF 
aligned with the corresponding transcript and gene graphical representations. (2) Form for selecting ORF exons for analysis. (3) 
Translated sequences of the selected ORF exons. (4) Form for selecting external websites to predict functional protein 
domains. (B) Multi-alignment of translated sequences of predicted ORFs. (1) Amino acids encoded by nucleotides from two 
exons (the amino acid is within the exon that yields two of the three codon nucleotides). (2) Methionines are represented by a 
green bold "M". (3) Red bold asterisks correspond to stop codons. (4) CDS from CCDS is highlighted in green.
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product, or a specific SV, or all SVs or subsets thereof that
give rise to PCR products of different sizes. For example,
Figure 7A explicitly shows the skipping of exon 5 in the
[GenBank:BC063849] transcript on the multi-alignment
(Figure 7A, item 2). The primer sequences can be selected
directly from this multi-alignment (Figure 7A, item 3),
then copied and pasted on the corresponding boxes (Fig-
ure 7A, item 4). Once the in silico PCR is run, general infor-
mation regarding input primers is displayed, including
length, GC percent, TM, location and sequence (Figure
7A, item 5). Fast DB provides the expected PCR product
length from each SV (Figure 7A, item 6). After clicking on
the corresponding link, the sequence of the PCR product
is displayed (Figure 7A, item 7) and is clickable in order to
display restriction enzyme cut sites for this sequence (pro-
vided by RestrictionMapper [45]). Fast DB also provides a
link to ASePCR [46] that displays the predicted PCR prod-
ucts expected in various tissues.
Finally, to assist the interpretation of microarray results,
the "probe alignment" tool graphically provides the loca-
tion of any sequence within the gene exon/intron struc-
ture, such as probes used in microarrays. Input sequences
can be located within an exon, an intron, an exon/intron
or an intron/exon junction, or an exon/exon junction. In
all cases, the input sequences must be at least 20 nucle-
otides long, but in the case of an exon/exon junction they
must cover at least 16 nucleotides of each exon. The exam-
ple displayed in Figure 7B corresponds to the alignment of
all Affymetrix exon-array core-level probes for the human
RANBP9 gene (69 sequences, each 25 nucleotides long).
Each of these probes is represented on the chart (Figure
7B, item 1), and their genomic positions, percentage iden-
tities with the genomic sequence and alignment lengths
are displayed in a table under the diagram. After clicking
on a given probe on the scheme, corresponding data in
the table are highlighted in red (Figure 7B, item 2), and
the corresponding probe alignment with the genomic
sequence is provided at the bottom of the page (Figure 7B,
item 3).
Forum and documentation
To provide interactive help in using fast DB, we set up a
forum in the "Forum/Documentation" section where
users are invited to post their comments. Furthermore, we
developed a quick help section by assembling short expla-
nations and legends of fast DB charts. A complete fast DB
documentation is available in PDF and HTML formats in
the "Forum/Documentation" section.
Discussion
In addition to describing the transcripts produced by
human and mouse genes, as already reported [4], the new
release of fast DB now provides tools that analyze the
putative function of these transcripts and the regulation of
their expression and therefore achieves an advance in AS
databases by allowing SVs for human and mouse
genomes to be interpreted functionally. To do that, fast
DB integrates information and tools for predicting the
functional consequences of AS. Several other databases
have assembled protein information or information
regarding AS. To try to correlate AS events with their func-
tional consequences, some AS databases integrate protein
sequences to annotate splicing events [47,48], while oth-
ers indicate translational product start positions, end posi-
tions and amino acid sequences corresponding to some
SVs [5,31,49-51]. The SpliceNest database even shows all
6-frame predicted ORFs [52]. However, none of these
databases integrates tools for predicting the functional
consequences of a given AS event. To the best of our
knowledge, fast DB is the first freely-available system to
offer direct links for making interactive predictions of
functional protein domains from alternative exons. The
next objective in the development of fast DB will be to
integrate structural protein domain analysis, as this kind
of domain has been shown to be altered by AS [2,53].
Furthermore, the translation of a given transcript can be
inhibited or degraded through the NMD pathway and/or
miRNA targeting. Therefore, transcripts that are predicted
to be targeted by the NMD pathway and/or miRNA are
indicated in fast DB. Only two databases containing NMD
data have previously been available. The first, called
"NMD database", comprises yeast data based on Affyme-
trix chip analyses with several UPF gene deletion condi-
tions. The second is the ASTRA database [31], which
indicates transcripts potentially targeted by NMD. How-
ever, ASTRA only contains 5,751 human genes and NMD
prediction is constructed only from full-length cDNA
sequences from UniGene. Several other databases contain
MicroRNA interaction site prediction Figure 4
MicroRNA interaction site prediction. (1) Name of 
microRNA. (2) Positions of alignment between microRNA 
and genomic sequences. (3) Length of alignment between 
microRNA and genomic sequences. (4) Link to alignment 
between microRNA and genomic sequences. (5) MicroRNA 
sequence aligned with genomic sequence. (6) Transcript 
sequences aligned with the genomic sequence located at the 
same alignment position.
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Tissue specificity analysis in fast DB Figure 5
Tissue specificity analysis in fast DB. (A) Tissue distribution of the 87 transcripts (cDNAs + ESTs) of the human RANBP9 
gene. (1) Link to the tissue distribution of all fast DB cDNAs and ESTs. (2) Color legend and abbreviations of tissues in which 
transcripts are expressed. (3) Histogram of the tissue distribution of the human RANBP9 gene transcripts. (4) List of alternative 
events available for tissue specificity analysis. (B) Tissue specificity analysis of the skipping of human RANBP9 gene exon 5. (1) 
Color legend and schematic representation of the different transcript groups constituted for the study of this event. (2) Splice 
site positions used to define the different groups of transcripts. (3) Histogram of transcript tissue distribution: the skipping of 
exon 5 (red) seems to occur specifically in muscular (and possibly nervous) tissue(s). (4) Table summarizing the tissue distribu-
tion values for the transcript.
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Analysis of the first exon of the [GenBank:AB055311] transcript Figure 6
Analysis of the first exon of the [GenBank:AB055311] transcript. (A) The fast DB page for the analysis of the first exon of 
the [GenBank:AB055311] transcript. (1) Graphical representation of the [GenBank:AB055311] transcript aligned with the 
exon/intron structure of the human RANBP9 gene. Exon 1 was selected for analysis and labeled in red. (2) Scoring of splice site 
strength for the first exon of the [GenBank:AB055311] transcript. (3) Length and sequence of the first exon of [Gen-
Bank:AB055311]. (4) Analyses available for the selected transcript exon: transcription, UTR or splicing analyses. (5) Website 
selection for analyzing the selected exon for 5'UTR sequences. (B) List of websites available for analysis.
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"In silico PCR" and "Probe alignment" tools infast DB Figure 7
"In silico PCR" and "Probe alignment" tools infast DB. (A) The "in silico PCR" option in fast DB. (1) Multi-alignment of 
transcript sequences of the human RANPB9 gene, exon by exon. (2) Explicit skipping of exon 5 by the [GenBank:BC063849] 
transcript shown on multi-alignment. (3) Direct selection of primers on multi-alignment. (4) Form for inputting primer 
sequences. (5) General information regarding input primers: length, GC percentage, TM, location and sequence. (6) Link to test 
the user's primers with ASePCR. (7) Expected PCR product for each transcript with its length and the link to its sequence. (8) 
Sequence of one expected PCR product, clickable in order to display the restriction enzyme cut sites for this sequence. (B) 
The "probe alignment" option in fast DB. (1) Graphical representation of probe sequences aligned with the genomic exon/
intron structure. (2) Table with alignment information for all aligned probe sequences; data regarding the selected probe are 
highlighted in red. (3) Alignment of the selected probe sequence with the genomic sequence.
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information on miRNA targets, but fast DB is the only AS
database that integrates the miRNA target feature in its
transcript catalogue.
To help predict the tissue specificity of AS, fast DB pro-
vides a tissue distribution chart for each splicing event.
Several studies have identified tissue-specific AS events
[15,54], and some AS databases present EST tissue-expres-
sion histograms [49,50]. ASAP even provides lists of tis-
sue-specific AS events by comparing the number of ESTs
in different tissues [51]. However, fast DB is the only tool
that provides a tissue distribution histogram for each
splicing and transcriptional event. A limitation of this bio-
informatic approach based on EST is that the number of
ESTs varies considerably among tissues.
In addition to providing tools for predicting the transla-
tion product, function and expression pattern of each SV,
fast DB offers tools to assist in their experimental analysis.
The "in silico PCR" option enables the user to design prim-
ers for PCR amplification easily. Furthermore, the "probe
alignment" tool provides a clear visualization of the
genomic alignment of any input sequences, such as
probes used in microarrays. In particular, the fast DB
probe alignment tool allows each Affymetrix "probe
selecting region" to be graphically associated with a given
region (i.e. either constitutive exon or alternative region).
Conclusion
Much effort has been devoted to setting up the most com-
plete transcript catalogue to date. This work is an ongoing
project and researchers must sustain their effort by provid-
ing new SVs to fill public databanks. In order to appre-
hend the role and impact of this transcriptome diversity in
gene function, biologists need tools that provide informa-
tion about the potential function of each SV, as well as its
expression pattern. In addition, the scientific community
using genomic/transcriptomic databases is increasing in
size and diversity, not least because splicing deregulation
is involved in many diseases [55], and the use of gene
expression studies is continually growing in clinical anal-
yses. Therefore, bioinformatic web interfaces have to be as
user-friendly as possible so that they are readily searchable
and intelligible at a glance by the whole biomedical com-
munity. We think that fast DB has reached the goal of pro-
viding a large number of bioinformatic tools that facilitate
the study of the regulation of human gene product expres-
sion and of integrating these tools in a user-friendly,
attractive and interactive web interface.
Availability and requirements
Fast DB is freely available for online use at http://
www.fast-db.com.
To display all graphical representations of fast DB (except
tissue distribution histograms), the user's web navigator
has to contain a flash plugin (freely downloadable at
http://www.adobe.com).
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